A Team Approach That Puts Patients First
A Team Approach That Puts Patients First
Our cancer center team, led by chief Dr. Matthew Kulke, works every day in the fight against cancer. The Center’s experienced cancer specialists combine their extensive knowledge and expert skills to focus on your individual needs. Our comprehensive, multi-specialty team approach to diagnosis, treatment, and follow-up ensures that the most up-to-date options and recommendations are offered in a timely and coordinated way.
Please call 617.638.6428 for new patient referrals.
My first appointment with the BMC Medical team was wonderful. I arrived with fear, without hope, but Dr. Michael Cassidy and Dr. Naomi Ko were empathetic, answered all my questions, made me feel safe and knew that I would overcome this disease.
Clinical Support Services
Patients with blood disorders receive consultation and treatment for a broad range of benign conditions, such as hemoglobinopathies (sickle cell anemia and thalassemia), hemochromatosis, bleeding and thrombotic disorders (von Willebrand's disease and hemophilia), hypercoagulable states, myeloproliferative disorders, myelodysplasia and anemia, and malignancies such as leukemia, lymphoma and myeloma.
The Cancer Care Center at Boston Medical Center cares for patients with malignant and non-malignant blood disorders and cancer. The Center provides diagnostic services, innovative treatments, and comprehensive care to patients by an outstanding, nationally recognized, multidisciplinary team of hematologists, oncologists, radiation oncologists, surgeons, oncology nurses, social workers, and dieticians.
The first step is a consultation with a radiation oncologist who works closely with other physicians and medical professionals to coordinate the best possible care for every patient.
Surgical oncologists provide comprehensive, expert surgical treatment for patients with a broad range of cancers. The team of surgeons, nurses, and support service personnel are among the best in the country, and the treatment approach, facilities, and technology available are state-of-the-art.
Resources for Patients
BMC researchers are finding innovative new ways to treat and cure cancers, including cancers of the breast, lung, colon, prostate, head and neck, blood cells (leukemia and lymphoma), and more.
As our patient, you'll have access to a wide range of clinical trials from both BMC researchers and researchers at other institutions. While we enroll any and all eligible patients in clinical trials, BMC physicians are in particular leaders in the enrollment of under-represented minorities in clinical trials.
Latest from HealthCity
CAR T, a personalized cell therapy, has been a game-changer for certain blood cancers, but its high cost has been a huge barrier to equitable access.
Historically marginalized communities are subject to delays across the spectrum of cancer care.
Eliminating the race-based health equity gap starts from within the department, says Boston University Chobanian & Avedisian School of Medicine
Using their own screening history, women can access the same type of personalized risk information that their doctors see.
BMC’s innovative clinic provides same-day shots and a chance to research barriers to vaccination.
New research shows the need for increased lung cancer screening in areas that are highly segregated by race to better diagnose Black patients early.
Guidelines recommend discontinuing cervical cancer screening at 65, but new research shows that the majority of women don't meet the criteria to stop.
A new collaboration among Boston cancer centers aims to increase minority populations’ access to the latest treatments for more equitable outcomes.
Black women die from breast cancer in higher rates than any other group. Major medical systems are collaborating to eliminate the growing disparity.
Healthcare experts share forward-thinking views on the medical community’s role in providing effective, authentic, and sustainable care.
At Boston Medical Center, experts from the Cancer Center are exploring how new and existing therapies could fight the COVID infection.
Being uninsured or enrolled in Medicaid is a major factor in the stage of breast cancer at diagnosis, a new study finds.